Peripheral Neuropathy Treatment Options are Getting Better with Continuous Research and Development Activities

 

Peripheral Neuropathy Treatment 

Neuropathy is a disease that affects the nerves inside the body. Most often this disease is caused by some form of diabetes. Symptoms may also arise from common health conditions. Treatment for peripheral neuropathy can include treating each symptom or finding the root cause. Treatments for peripheral neuropathy can also include using medication to help control blood glucose levels.

Transcutaneous Electrical Nerve Stimulation (TENS) is a major peripheral neuropathy treatment. It is done through the application of tiny electrical currents through the skin. A machine is used to provide these electrical pulses. The current applied is often sufficient to stop a person from feeling pain, although it normally takes longer for a nerve to become completely cut off. There are several advantages to TENS over other traditional forms of treating peripheral neuropathy, including the fact that there is no medication to administer during a session and the fact that it is safe.

Several peripheral neuropathies can be helped with peripheral neuropathy surgery. The two most common types of surgery used to treat diabetic peripheral neuropathies are tunnel syndrome and extracorporeal shock wave therapy (ESWTA). The tunnel syndrome involves splitting a spinal nerve away from its attachment to several nerves in the back or upper body. This enables the damaged nerve to be relieved from its location, allowing it to send signals to a specific area of the body

Extracorporeal Shock Wave Therapy involves the administration of electric shocks to the affected area. These electrical impulses cause damage to the nerves in the surrounding area. Doctors use various options for patients with diabetic peripheral neuropathy treatment. They will discuss the medical history and symptoms with the patient and will administer treatment based on the diagnosis and treatment plan. In 2019, Japanese drugmaker Daiichi Sankyo won regulatory approval for Tarlige, an oral formulation for the peripheral neuropathy treatment.